Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 7751 - 7775 of 8109 in total

(2S)-1-(Dimethylamino)-3-(4-{[4-(2-methylimidazo[1,2-a]pyridin-3-yl)-2-pyrimidinyl]amino}phenoxy)-2-propanol

Experimental

PD-166326

Experimental

2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE

Experimental

(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE

Experimental

3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE

Experimental

2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE

Experimental

Brifentanil

Brifentanil (also known as A-3331) is an analog of fentanyl, a potent opioid. This drug is classified as an opioid analgesic and was developed in the early 1990s. The effects of brifentanil are very similar to those of alfentanil, with strong but short lasting analgesia and sedation, and particularly notable...
Illicit

Lortalamine

Lortalamine (LM-1404) is a selective norepinephrine reuptake inhibitor developed in the 1980s. This drug never made it past clinical trials, likely due to ocular toxicity in animals, but has been used in positron emission tomography studies to label norepinephrine transporters.
Experimental

Laninamivir octanoate

Laninamivir octanoate has been used in trials studying the treatment of Asthma.
Investigational

Epelsiban

Epelsiban has been investigated for the treatment of Premature Ejaculation.
Investigational

Sepetaprost

Sepetaprost has been used in trials studying the treatment of Open Angle-glaucoma, Ocular Hypertension, and Mild Open Angle-glaucoma (OAG).
Investigational

PF-03654746

PF-03654746 has been investigated for the treatment of Narcolepsy, Schizophrenia, Tourette's Syndrome, and Excessive Daytime Sleepiness.
Investigational

Ifetroban

Ifetroban has been used in trials studying the treatment of Skin Diseases, Autoimmune Diseases, Pathologic Processes, Scleroderma, Limited, and Scleroderma, Diffuse, among others.
Investigational

PF-03654764

PF-03654764 has been used in trials studying the basic science and treatment of Allergic Rhinitis.
Investigational

Silatecan

Silatecan has been used in trials studying the treatment of GBM, Tumors, Gliosarcoma, Solid Malignancies, and Glioblastoma Multiforme, among others.
Investigational

GLPG-0492

Glpg0492 is under investigation in clinical trial NCT01130818 (First-in-Human Single Ascending Dose of GLPG0492).
Investigational

BMS-911543

BMS-911543 has been used in trials studying the treatment of Cancer.
Investigational

Aleplasinin

Aleplasinin has been investigated in Alzheimer Disease.
Investigational

BMS-908662

BMS-908662 has been used in trials studying the treatment of Melanoma and Colorectal Cancer.
Investigational

PF-00217830

PF-00217830 has been used in trials studying the treatment of Schizophrenia.
Investigational

TAK-593

TAK-593 has been used in trials studying the treatment of Solid Tumors.
Investigational

Saroglitazar

Saroglitazar has been investigated for the treatment of Fatty Liver.
Investigational

Gitoformate

Experimental

Alcuronium

A non-depolarizing skeletal muscle relaxant similar to tubocurarine. It is used as an anesthesia adjuvant.
Experimental

VB-201

VB-201 is under investigation in clinical trial NCT01001468 (Study to Assess VB-201 in Patients With Psoriasis).
Investigational
Displaying drugs 7751 - 7775 of 8109 in total